Coronavirus impact: India withdraws export ban on 12 essential medicines
Directorate General of Foreign Trade (DGFT) said the ban imposed on the export of these medicines a month ago is no longer in force
- Apr 6, 2020,
- Updated Apr 6, 2020 11:40 PM IST
India has withdrawn the ban imposed on export of 12 bulk drugs - raw materials for finished drugs - and essential medicines like antibiotics and vitamins manufactured using them, with immediate effect.
In a notification issued on April 6, the Directorate General of Foreign Trade (DGFT) said the ban imposed on the export of these medicines a month ago is no longer in force.
The medicines that are out of the restricted category now are tinidazole, metronidazole, acyclovir, vitamin B1, vitamin B6, vitamin B12, progesterone, chloramphenicol, erythromycin, clindamycin and ornidazole.
Two coronavirus vaccine candidates enter human trials, 60 in pre-clinical stage: WHO
India has withdrawn the ban imposed on export of 12 bulk drugs - raw materials for finished drugs - and essential medicines like antibiotics and vitamins manufactured using them, with immediate effect.
In a notification issued on April 6, the Directorate General of Foreign Trade (DGFT) said the ban imposed on the export of these medicines a month ago is no longer in force.
The medicines that are out of the restricted category now are tinidazole, metronidazole, acyclovir, vitamin B1, vitamin B6, vitamin B12, progesterone, chloramphenicol, erythromycin, clindamycin and ornidazole.
Two coronavirus vaccine candidates enter human trials, 60 in pre-clinical stage: WHO